Aadi Bioscience Q4 GAAP EPS $(0.60) Beats $(0.65) Estimate, Sales $6.33M Beat $6.29M Estimate

Aadi Bioscience (NASDAQ:AADI) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0.65) by 7.69 percent. This is a 15.38 percent decrease over losses of $(0.52) per share from the same period last year. The company reported quarterly sales of $6.33 million which beat the analyst consensus estimate of $6.29 million by 0.57 percent. This is a 21.03 percent increase over sales of $5.23 million the same period last year.